152 related articles for article (PubMed ID: 20980741)
1. A pilot study of rituximab in immune-mediated inner ear disease.
Cohen S; Roland P; Shoup A; Lowenstein M; Silverstein H; Kavanaugh A; Harris J
Audiol Neurootol; 2011; 16(4):214-21. PubMed ID: 20980741
[TBL] [Abstract][Full Text] [Related]
2. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
[TBL] [Abstract][Full Text] [Related]
3. Theoretical and practical implications for plasmapheresis in autoimmune inner ear disease.
Luetje CM
Laryngoscope; 1989 Nov; 99(11):1137-46. PubMed ID: 2811552
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated inner ear disease.
Bovo R; Aimoni C; Martini A
Acta Otolaryngol; 2006 Oct; 126(10):1012-21. PubMed ID: 16923703
[TBL] [Abstract][Full Text] [Related]
5. [Testing of related antibodies against inner ear tissues and clinical observation on autoimmune inner ear disease].
Zhai SQ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(6):353-5, 382. PubMed ID: 8031589
[TBL] [Abstract][Full Text] [Related]
6. Cochlear implantation outcomes in patients with autoimmune and immune-mediated inner ear disease.
Aftab S; Semaan MT; Murray GS; Megerian CA
Otol Neurotol; 2010 Oct; 31(8):1337-42. PubMed ID: 20729775
[TBL] [Abstract][Full Text] [Related]
7. [Acute bilateral sensorineural hearing loss caused by immuno-mediated inner ear disease].
Abbate A; Viaggio MB; Piras D; López L; Hubscher O; Nogués M
Medicina (B Aires); 2001; 61(6):860-2. PubMed ID: 11808429
[TBL] [Abstract][Full Text] [Related]
8. [Progressive sensorineural hearing loss: immunologic etiology].
Berrettini S; Ravecca F; Bruschini L; Ursino F; Sellari-Franceschini S
Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):33-41. PubMed ID: 10205931
[TBL] [Abstract][Full Text] [Related]
9. Pediatric fluctuating sensorineural hearing loss: problems in medical management.
Dinces EA; Yang S; Balogun AO
Laryngoscope; 2001 Jan; 111(1):21-5. PubMed ID: 11192894
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated inner ear disorders.
Moscicki RA
Baillieres Clin Neurol; 1994 Nov; 3(3):547-63. PubMed ID: 7874408
[TBL] [Abstract][Full Text] [Related]
11. [Immune-mediated inner ear disease: report of clinical cases].
García Berrocal JR; Arellano B; Vargas JA; Trinidad A; Ramírez Camacho R; Vergara J
Acta Otorrinolaringol Esp; 1997 Oct; 48(7):565-70. PubMed ID: 9489160
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation and treatment of immune-mediated inner ear disease.
Welling DB
Ear Nose Throat J; 1996 May; 75(5):301-5. PubMed ID: 8935529
[TBL] [Abstract][Full Text] [Related]
13. [Immunologic findings and therapeutic results in chronic progressive inner ear hearing loss].
Kempf HG; Hörnig T
HNO; 1987 Jan; 35(1):38-42. PubMed ID: 3549637
[TBL] [Abstract][Full Text] [Related]
14. Auditory function in women with autoimmune inner ear diseases and their offspring.
Tan CQ; Dong WD; Guo L; Huang H; Wang DY
Int J Pediatr Otorhinolaryngol; 2009 Dec; 73(12):1702-11. PubMed ID: 19804914
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatment of immune-mediated inner ear disorders. A clinical immunology and audiology survey.
Veldman JE
Scand Audiol Suppl; 1986; 26():21-6. PubMed ID: 3472327
[TBL] [Abstract][Full Text] [Related]
16. [Immunology of the inner ear].
Rudack C
HNO; 1995 May; 43(5):275-81. PubMed ID: 7607911
[TBL] [Abstract][Full Text] [Related]
17. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss.
Harris JP; Sharp PA
Laryngoscope; 1990 May; 100(5):516-24. PubMed ID: 2329911
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune hearing loss.
Plester D; Soliman AM
Am J Otol; 1989 May; 10(3):188-92. PubMed ID: 2665508
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
El-Hallak M; Binstadt BA; Leichtner AM; Bennett CM; Neufeld EJ; Fuhlbrigge RC; Zurakowski D; Sundel RP
J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
[TBL] [Abstract][Full Text] [Related]
20. Rituximab and its use in autoimmune bullous disorders.
Daniel BS; Murrell DF; Joly P
Dermatol Clin; 2011 Oct; 29(4):571-5. PubMed ID: 21925000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
